Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 0,33 M
EBIT 2015 -34,5 M
Net income 2015 -34,9 M
Debt 2015 -
Yield 2015 -
Sales 2016 3,67 M
EBIT 2016 -45,6 M
Net income 2016 -45,9 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 910x
Capi. / Sales 2016 82,7x
Capitalization 303 M
More Financials
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
More about the company
Latest news on ANTA PHAR
06/26 Anthera Pharmaceuticals Added to the Russell 2000(R) and Russell 3000(R) Inde..
06/17 ANTHERA PHARMACEUTICALS : Has Reached Enrollment Target in CHABLIS-SC1 Phase 3 C..
06/16 Anthera Pharmaceuticals Has Reached Enrollment Target in CHABLIS-SC1 Phase 3 ..
06/05 ANTHERA PHARMACEUTICALS : Announces Additional Data on Patient-Reported Outcomes..
06/04 Anthera Pharmaceuticals Announces Additional Data on Patient-Reported Outcome..
05/27 Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
05/18 ANTHERA PHARMACEUTICALS : Reports 2015 First Quarter and Operational Update
05/12 ANTHERA PHARMACEUTICALS : Reports 2015 First Quarter and Operational Update
More news
Sector news : Biopharmaceuticals
05:46pDJNovartis Heart Failure Drug Approved by FDA
05:43pDJNovartis Heart Failure Drug Approved by FDA
04:59p NOVARTIS : FDA approves new heart failure pill from Novartis
More sector news : Biopharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions